Search
forResearch 10 of 1000+
- Healthcare innovation and patent law’s ‘pharmaceutical privilege’: is there a pharmaceutical privilege? And if so, should we remove it?
- Purpose-limited pharmaceutical product claims under the revised European Patent Convention: A camouflaged attack on generic substitution?
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Generic competition and pharma patent strategies - a sequel
- Medical treatment methods, medical indication claims and patentability: A quest into the rationale of the exclusion and patentability in the context of the future of personalised medicine
- Cases update: international roundup of recently filed cases and noteworthy rulings
- Court of Appeal can overrule itself to follow the EPO: UK adopts EPO stance on second medical use claims
- The Pharma Market as Reflected by Patents
- Applications of Nanostructured Lipid Carriers: Recent Advancements and Patent Review
- DTC pharmaceutical advertising: the debate’s not over
Community 10 of 50
- Potentially Positive Pyrilutamide News Coming
- Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026
- Pelage Pharmaceuticals with an absolute stunner of a molecule
- Not all generic medications are made equal. Some work great, some weaker, and some are dangerous. What Pharmaceutical makes your current/past generic Finasteride?
- Brief update clascoterone phase 3 - Breezula
- Indiamart anyone has used these ones before?
- Is there any new drug that looks promising ?
- PP405: Regrows Hair In 8 Weeks. Is This The Miracle Cure?
- Pelage Pharmaceutical Raises 120 million to continue PP405 Research. Link inside.
- Kintor Pharmaceutical’s KX-826 Shows Promising Results in Hair Loss Study